Outlook Therapeutics OTLK
NASDAQ OTLK
$0.56 +0.04 (+7.94%)
At close: Oct 21, 2026 · 4:00 PM EDT

Outlook Therapeutics (OTLK) Asset Utilization Ratio (2016 - 2026)

Updated

Outlook Therapeutics' Asset Utilization Ratio came in at 0.38 for fiscal Q4 2025 (quarter ended Sep 30, 2025), down 7.4% from the prior quarter.

Analysis

Outlook Therapeutics (OTLK) Asset Utilization Ratio (2016 - 2026) Analysis & Trends

For FY2025 (ended Sep 30, 2025), Outlook Therapeutics' Asset Utilization Ratio was 0.06.

  • The fiscal Q4 2025 figure represents the lowest quarterly Asset Utilization Ratio since fiscal Q4 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 0.62
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 0.49
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 0.47
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 0.52
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 0.46
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 0.51
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 0.40
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 0.58
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 0.31
10 Outlook Therapeutics 77.51 Mn 41.76 Mn -8,265.00 -0.01
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.01
Mar 31, 2026 0.07
Dec 31, 2025 0.07
Sep 30, 2025 0.07
Jun 30, 2025 0.04
Mar 31, 2025 -0.02
Dec 31, 2024 -0.15
Sep 30, 2024 -0.09
Jun 30, 2024 -0.04
Mar 31, 2024 -0.06
Dec 31, 2023 0.04
Sep 30, 2023 -0.04
Jun 30, 2023 -0.05
Mar 31, 2023 -0.05
Dec 31, 2022 -0.08
Sep 30, 2022 -0.05
Jun 30, 2022 -0.02
Mar 31, 2022 -0.02
Dec 31, 2021 -0.02
Sep 30, 2021 -0.04
API Access

Outlook Therapeutics Asset Utilization Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=OTLK&period=max&api_key=YOUR_API_KEY